Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Fruchart

Showing results (551-560 of 562) with videos related to

Pageof 57
Sort By:
The Journal of Biological Chemistry|July 25, 1997
The organization, promoter analysis, and expression of the human PPARgamma geneL Fajas, D Auboeuf, E Raspé, et al.
European Journal of Clinical Investigation|March 27, 1999
Lipid and lipoprotein analysis of cats with lipoprotein lipase deficiencyD G Ginzinger, S M Clee, J Dallongeville, et al.
Atherosclerosis|December 4, 2003
Heterozygosity for ABCA1 gene mutations: effects on enzymes, apolipoproteins and lipoprotein particle sizeJ A Kuivenhoven, G K Hovingh, A van Tol, et al.
Leukemia|July 20, 2007
Long-term follow-up of high-dose treatment with autologous haematopoietic progenitor cell support in 693 patients with follicular lymphoma: an EBMT registry studyS Montoto, C Canals, A Z S Rohatiner, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 14, 2012
Phase III study of ACVBP versus ACVBP plus rituximab for patients with localized low-risk diffuse large B-cell lymphoma (LNH03-1B)N Ketterer, B Coiffier, C Thieblemont, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 24, 2013
Lymphoma occurring in patients over 90 years of age: characteristics, outcomes, and prognostic factors. A retrospective analysis of 234 cases from the LYSAA Trebouet, T Marchand, R Lemal, et al.
British Journal of Pharmacology|December 18, 2009
Isolation and pharmacological characterization of AdTx1, a natural peptide displaying specific insurmountable antagonism of the alpha1A-adrenoceptorL Quinton, E Girard, A Maiga, et al.
Blood|July 14, 2017
FDG-PET-driven consolidation strategy in diffuse large B-cell lymphoma: final results of a randomized phase 2 studyR-O Casasnovas, L Ysebaert, C Thieblemont, et al.
Bone Marrow Transplantation|May 29, 1998
Early intensive therapy with autologous stem cell transplantation in advanced Hodgkin's disease: retrospective analysis of 158 cases from the French registryP Moreau, J Fleury, P Brice, et al.
Hematological Oncology|October 1, 2024
Real-world data for marginal zone lymphoma patients in the French REALYSA cohort: The REALMA studyC Bommier, M Donzel, C Rossi, et al.
Pageof 57

Showing results (551-560 of 562) with videos related to

Sort By:
Pageof 57
The Journal of Biological Chemistry|July 25, 1997
The organization, promoter analysis, and expression of the human PPARgamma geneL Fajas, D Auboeuf, E Raspé, et al.
European Journal of Clinical Investigation|March 27, 1999
Lipid and lipoprotein analysis of cats with lipoprotein lipase deficiencyD G Ginzinger, S M Clee, J Dallongeville, et al.
Atherosclerosis|December 4, 2003
Heterozygosity for ABCA1 gene mutations: effects on enzymes, apolipoproteins and lipoprotein particle sizeJ A Kuivenhoven, G K Hovingh, A van Tol, et al.
Leukemia|July 20, 2007
Long-term follow-up of high-dose treatment with autologous haematopoietic progenitor cell support in 693 patients with follicular lymphoma: an EBMT registry studyS Montoto, C Canals, A Z S Rohatiner, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 14, 2012
Phase III study of ACVBP versus ACVBP plus rituximab for patients with localized low-risk diffuse large B-cell lymphoma (LNH03-1B)N Ketterer, B Coiffier, C Thieblemont, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 24, 2013
Lymphoma occurring in patients over 90 years of age: characteristics, outcomes, and prognostic factors. A retrospective analysis of 234 cases from the LYSAA Trebouet, T Marchand, R Lemal, et al.
British Journal of Pharmacology|December 18, 2009
Isolation and pharmacological characterization of AdTx1, a natural peptide displaying specific insurmountable antagonism of the alpha1A-adrenoceptorL Quinton, E Girard, A Maiga, et al.
Blood|July 14, 2017
FDG-PET-driven consolidation strategy in diffuse large B-cell lymphoma: final results of a randomized phase 2 studyR-O Casasnovas, L Ysebaert, C Thieblemont, et al.
Bone Marrow Transplantation|May 29, 1998
Early intensive therapy with autologous stem cell transplantation in advanced Hodgkin's disease: retrospective analysis of 158 cases from the French registryP Moreau, J Fleury, P Brice, et al.
Hematological Oncology|October 1, 2024
Real-world data for marginal zone lymphoma patients in the French REALYSA cohort: The REALMA studyC Bommier, M Donzel, C Rossi, et al.
Pageof 57